Skip to Content

Alnylam Pharmaceuticals

ALNY

Buy $ALNY at eToro
Rank 915
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US

Alnylam Pharmaceuticals - Key figures

Market cap 15.28 Billion
Revenue 879.98 Million
Profit 704.14 Million
P/E Ratio No information
P/s Ratio 17.36
Buy $ALNY at eToro

Alnylam Pharmaceuticals - Description

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies.

The company is headquartered in Cambridge, Massachusetts.